Piramal Pharma Q3 Results

  • BSE: 543635
  • NSE: PPLPHARMA
  • ISIN: INE0DK501011
  • Sector: -
BSE
235.254.00 (1.73%)
Volume1.42 M
Updated: Wed 11 Sep, 2024 | 15:58:50
NSE
235.313.87 (1.67%)
Volume36.96 M
Updated: Wed 11 Sep, 2024 | 15:44:41
Today: 232.15
244.10
52-Wk: 87.55
239.45

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Piramal Pharma Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ Comp
    Total Revenue 1,958.571,911.382.47%
    Selling/ General/ Admin Expenses Total 523.78516.031.50%
    Depreciation/ Amortization 186.32184.510.98%
    Other Operating Expenses Total -61.51-49.1925.05%
    Total Operating Expense 1,356.011,289.085.19%
    Operating Income 602.56622.30-3.17%
    Net Income Before Taxes 19.3639.56-51.06%
    Net Income 10.115.02101.39%
    Diluted Normalized EPS 0.210.04433.38%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts